Company intelligence / Profile preview

FasTraQ

Indianapolis, Indiana, United States

Ownership: Private
Development stage: Other

Overview

FasTraQ is a healthcare technology company that provides a specialized cloud-based platform for the management and tracking of radiopharmaceuticals. The company's software solutions are designed to streamline the complex logistics associated with Positron Emission Tomography (PET) and Single-Photon Emission Computed Tomography (SPECT) imaging agents. By offering real-time tracking, dose management, and regulatory compliance tools, FasTraQ helps clinical sites and radiopharmacies optimize their supply chain and ensure patient safety. The platform is particularly focused on the unique challenges of short-lived isotopes, providing a critical link between manufacturers and clinical end-users.

Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on FasTraQ.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FasTraQ.

Explore the full profile